1. Tatro DS. Drug interaction fact. 3rd ed. St Louis (MO): Facts and Comparisons;1992.
2. Fokter N, Mozina M, Brvar M. Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments. Wien Klin Wochenschr. 2010; 122(3-4):81–88.
3. Hamilton RA, Briceland LL, Andritz MH. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacotherapy. 1998; 18(5):1112–1120.
4. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf. 1993; 9(1):51–59.
5. Pasina L, Djade CD, Nobili A, Tettamanti M, Franchi C, Salerno F, et al. Drug-drug interactions in a cohort of hospitalized elderly patients. Pharmacoepidemiol Drug Saf. 2013; 22(10):1054–1060.
6. Teich JM, Osheroff JA, Pifer EA, Sittig DF, Jenders RA. CDS Expert Review Panel. Clinical decision support in electronic prescribing: recommendations and an action plan: report of the joint clinical decision support workgroup. J Am Med Inform Assoc. 2005; 12(4):365–376.
7. Smithburger PL, Buckley MS, Bejian S, Burenheide K, Kane-Gill SL. A critical evaluation of clinical decision support for the detection of drug-drug interactions. Expert Opin Drug Saf. 2011; 10(6):871–882.
8. van der Sijs H, Mulder A, van Gelder T, Aarts J, Berg M, Vulto A. Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol Drug Saf. 2009; 18(10):941–947.
9. Mille F, Schwartz C, Brion F, Fontan JE, Bourdon O, Degoulet P, et al. Analysis of overridden alerts in a drug-drug interaction detection system. Int J Qual Health Care. 2008; 20(6):400–405.
10. van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006; 13(2):138–147.
11. Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med. 2003; 163(21):2625–2631.
12. Rosenberg SN, Sullivan M, Juster IA, Jacques J. Over-rides of medication alerts in ambulatory care. Arch Intern Med. 2009; 169(14):1337.
13. Ahearn MD, Kerr SJ. General practitioners' perceptions of the pharmaceutical decision-support tools in their prescribing software. Med J Aust. 2003; 179(1):34–37.
14. Shah NR, Seger AC, Seger DL, Fiskio JM, Kuperman GJ, Blumenfeld B, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc. 2006; 13(1):5–11.
15. van der Sijs H, Aarts J, van Gelder T, Berg M, Vulto A. Turning off frequently overridden drug alerts: limited opportunities for doing it safely. J Am Med Inform Assoc. 2008; 15(4):439–448.
16. Smithburger PL, Kane-Gill SL, Benedict NJ, Falcione BA, Seybert AL. Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings. Ann Pharmacother. 2010; 44(11):1718–1724.
17. Bottiger Y, Laine K, Andersson ML, Korhonen T, Molin B, Ovesjo ML, et al. SFINX-a drug-drug interaction database designed for clinical decision support systems. Eur J Clin Pharmacol. 2009; 65(6):627–633.
18. Tamblyn R, Huang A, Taylor L, Kawasumi Y, Bartlett G, Grad R, et al. A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care. J Am Med Inform Assoc. 2008; 15(4):430–438.
19. van der Sijs H, Lammers L, van den Tweel A, Aarts J, Berg M, Vulto A, et al. Time-dependent drug-drug interaction alerts in care provider order entry: software may inhibit medication error reductions. J Am Med Inform Assoc. 2009; 16(6):864–868.
20. Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006; 9(3):427–433.
21. Vonbach P, Dubied A, Krahenbuhl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med. 2008; 19(6):413–420.
22. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007; 16(6):641–651.
23. Ahn EK, Kam HJ, Park DK, Jung EY, Lee Y, Park RW. Differences among admitting departments in alerts and alert overrides for drug-drug interaction. Pharmacoepidemiol Drug Saf. 2014; 23(4):390–397.
24. Grizzle AJ, Mahmood MH, Ko Y, Murphy JE, Armstrong EP, Skrepnek GH, et al. Reasons provided by prescribers when overriding drug-drug interaction alerts. Am J Manag Care. 2007; 13(10):573–578.
25. Korea Ministry of Food and Drug Safety. Act for ingredient of contraindicated co-prescriptions of medicine [Internet]. Cheongju, Korea: Ministry of Food and Drug Safety;c2014. cited at 2014 Jun 25. Available from:
http://www.mfds.go.kr/index.do?mid=687&seq=7646&cmd=v.
26. Isaac T, Weissman JS, Davis RB, Massagli M, Cyrulik A, Sands DZ, et al. Overrides of medication alerts in ambulatory care. Arch Intern Med. 2009; 169(3):305–311.
27. Taylor LK, Tamblyn R. Reasons for physician non-adherence to electronic drug alerts. Stud Health Technol Inform. 2004; 107(Pt 2):1101–1105.
28. Zwart-van Rijkom JE, Uijtendaal EV, ten Berg MJ, van Solinge WW, Egberts AC. Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J Clin Pharmacol. 2009; 68(2):187–193.
29. Mantyselka P, Kumpusalo E, Ahonen R, Kumpusalo A, Kauhanen J, Viinamaki H, et al. Pain as a reason to visit the doctor: a study in Finnish primary health care. Pain. 2001; 89(2-3):175–180.
30. Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther. 2002; 27(5):377–382.
31. Glassman PA, Simon B, Belperio P, Lanto A. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care. 2002; 40(12):1161–1171.
32. Seidling HM, Klein U, Schaier M, Czock D, Theile D, Pruszydlo MG, et al. What, if all alerts were specific - estimating the potential impact on drug interaction alert burden. Int J Med Inform. 2014; 83(4):285–291.
33. Seidling HM, Phansalkar S, Seger DL, Paterno MD, Shaykevich S, Haefeli WE, et al. Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support. J Am Med Inform Assoc. 2011; 18(4):479–484.